Investor Frequently Asked Questions

Q. Where is Opexa’s stock traded?

A. Opexa’s shares are traded on the NASDAQ Capital Market under the symbol "OPXA".

Q. When did the company become publicly traded?

A. Opexa Therapeutics, Inc. became a publically traded company in 2004.

Q. Where are Opexa’s headquarters located?

A. Opexa Therapeutics, Inc.
2635 Technology Forest Blvd.
The Woodlands, TX 77381
Phone: 281.775.0600

Q. When does Opexa’s fiscal year end?

A. Opexa’s fiscal year ends December 31

Q. Who is Opexa’s independent auditor?

A. MaloneBailey, LLP
10350 Richmond Ave Suite 800
Houston, TX 77042

Q. How can I buy Opexa stock?

A. You may purchase Opexa stock through a registered stockbroker.

Q. What is Opexa’s CUSIP number?

A. CUSIP Number 68372T 10 3.

Q. Does Opexa have a direct stock purchase plan?

A. No. Shares can be purchased through a registered or discount stock brokerage firm.

Q. Whom should I contact with questions about my stock ownership?

A. Beneficial shareholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered shareholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Opexa’s transfer agent.

Q. Who is Opexa’s transfer agent?

A. Continental Stock Transfer & Trust Company
17 Battery Place, New York, NY 10004
cstmail@continentalstock.com
(212) 509-4000, ext. 541

Q. Where can I find financial information about Opexa?

A. Opexa files periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on our SEC Filings page, or at www.sec.gov. In addition, Opexa posts recent financial information in the form of quarterly earnings press releases here on the Press Releases page.

Q. How can I sign up to receive Opexa 's press releases and other company information?

A. Click here to be added to Opexa’s distribution list.